[1] Wu H, Zeng J, Yin J, et al. Organ-specific biomarkers in lupus[J]. Autoimmun Rev, 2017, 16: 391-397. [2] Klarquist J, Zhou Z, Shen N, et al. Dendritic cells in systemic lupus erythematosus: from pathogenic players to therapeutic tools[J]. Mediators Inflamm, 2016, 2016: 5045248. doi: 10.1155/2016/5045248. [3] Zhou H, Wu L. The development and function of dendritic cell populations and their regulation by miRNAs[J]. Protein Cell, 2017, 8: 501-513. [4] Teng X, Brown J, Choi SC, et al. Metabolic determinants of lupus pathogenesis[J]. Immunol Rev, 2020, 295: 167-186. [5] Carvalheiro T, Zimmermann M, Radstake T, et al. Novel insights into dendritic cells in the pathogenesis of systemic sclerosis[J]. Clin Exp Immunol, 2020, 201: 25-33. [6] Kim SJ. SLE-associated risk factors affect DC function[J]. Curr Rheumatol Rep, 2019, 21: 4-10. [7] Wang Y, Liang J, Qin H, et al. Elevated expression of miR-142-3p is related to the pro-inflammatory function of monocyte-derived dendritic cells in SLE[J]. Arthritis Res Ther, 2016, 18: 263-273. [8] Tian S, Liu X, Fan Q, et al. Microarray expression and functional analysis of circular RNAs in the glomeruli of NZB/W F1 mice with lupus nephritis[J]. Exp Ther Med, 2019, 18: 2813-2824. [9] Murata K, Furu M, Yoshitomi H, et al. Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis[J]. PLoS One, 2013, 8: e69118. doi: 10.1371/journal.pone.0069118. [10] Saeed AM, Mogahed MM. Systemic lupus erythmatosus is associated with disturbed cytokine milieu and increased TNF-related apoptosis-induced ligand levels[J]. Egypt J Immunol, 2016, 23: 75-85. [11] Tsai HC, Han MH. Sphingosine-1-phosphate (S1P) and S1P signaling pathway: therapeutic targets in autoimmunity and inflammation[J]. Drugs, 2016, 76: 1067-1079. [12] Aterido A, Julià A. Genome-wide pathway analysis identifies VEGF pathway association with oral ulceration in systemic lupus erythematosus[J]. Arthritis Res Ther, 2017, 19: 138-148. [13] Shu J, Li L, Zhou LB, et al. IRF5 is elevated in childhood-onset SLE and regulated by histone acetyltransferase and histone deacetylase inhibitors[J]. Oncotarget, 2017, 8: 47184-47194. [14] Scharer CD, Blalock EL, Mi T, et al. Epigenetic programming underpins B cell dysfunction in human SLE[J]. Nat Immunol, 2019, 20: 1071-1082. [15] Wang Z, Chang C, Lu Q. Epigenetics of CD4+ T cells in autoimmune diseases[J]. Curr Opin Rheumatol, 2017, 29: 361-368. |